Unlocking the Therapeutic Potential of Ulotaront as a Trace Amine-Associated Receptor 1 Agonist for Neuropsychiatric Disorders

Unlocking the Therapeutic Potential of Ulotaront as a Trace Amine-Associated Receptor 1 Agonist for Neuropsychiatric Disorders

All antipsychotics currently used in clinic block D2 dopamine receptors. Trace amine-associated receptor 1 is emerging as a new therapeutic target for schizophrenia and several other neuropsychiatric disorders. SEP-363856 (International Nonproprietary Name: Ulotaront) is an investigational antipsych...

Full description

Bibliographic Details
Main Authors: Savelii R. Kuvarzin, Ilya Sukhanov, Kirill Onokhin, Konstantin Zakharov, Raul R. Gainetdinov
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Biomedicines
Subjects:
SEP-363856
antipsychotic agents
dopamine
schizophrenia
ulotaront
trace amine-associated receptor 1
Online Access:https://www.mdpi.com/2227-9059/11/7/1977

Internet

https://www.mdpi.com/2227-9059/11/7/1977

Similar Items